Steven Doares

This profile gathers the share dealings of Steven Doares in Cellectis, where the filings describe the role as senior executive. We count 2 filings; the first trade dates from 3 March 2025 and the latest from 24 May 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 31 March 2026, the filings show a share grant in Cellectis. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.